chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Myalgia, Nausea, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (heartburn), ILLNESS (in bed sick), FEELING OF BODY TEMPERATURE CHANGE (hot and cold), FATIGUE (fatigue) and CHILLS (chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031H21A, 044A21A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Hypothyroidism, Hypertension and Triglycerides. Concomitant products included CHONDROITIN SULFATE, GLUCOSAMINE HYDROCHLORIDE (CHONDROITIN GLUCOSAMIN) for Arthritis, ALLOPURINOL, BIOTIN, CALCIUM CITRATE, CELECOXIB, CLONAZEPAM, COLLAGEN, DILTIAZEM, CONJUGATED LINOLEIC ACID, LINUM USITATISSIMUM SEED OIL, UBIDECARENONE (COQ10 [CONJUGATED LINOLEIC ACID;LINUM USITATISSIMUM SEED OIL;UBIDECARENONE]), ESOMEPRAZOLE, GABAPENTIN, BISACODYL (LAXATIVE [BISACODYL]), GLIPIZIDE, HYDROCHLOROTHIAZIDE, LORATADINE, LOSARTAN, IRON, PAROXETINE, DOCUSATE SODIUM (STOOL SOFTENER), DENOSUMAB (PROLIA), RISPERIDONE, ROSUVASTATIN, LEVOTHYROXINE SODIUM (SYNTHROID), HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE HCTZ), CURCUMA LONGA ROOT, PIPER NIGRUM FRUIT (TURMERIC CURCUMIN [CURCUMA LONGA ROOT;PIPER NIGRUM FRUIT]) and COLECALCIFEROL (VITAMIN D3) for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Nov-2021, the patient experienced DYSPEPSIA (heartburn), ILLNESS (in bed sick), FEELING OF BODY TEMPERATURE CHANGE (hot and cold), FATIGUE (fatigue), CHILLS (chills), NAUSEA (nausea), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and VACCINATION SITE PAIN (arm little sore). The patient was treated with CALCIUM CARBONATE, MAGNESIUM CARBONATE (TUMS [CALCIUM CARBONATE;MAGNESIUM CARBONATE]) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, DYSPEPSIA (heartburn) and VACCINATION SITE PAIN (arm little sore) had not resolved and ILLNESS (in bed sick), FEELING OF BODY TEMPERATURE CHANGE (hot and cold), FATIGUE (fatigue), CHILLS (chills), NAUSEA (nausea), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site pain
Clinical narrative: sore injection site arm after each vaccine; greater than 36 days between doses of Moderna Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore injection site arm after each vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 36 days between doses of Moderna Covid-19 vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore injection site arm after each vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 36 days between doses of Moderna Covid-19 vaccine). At the time of the report, VACCINATION SITE PAIN (sore injection site arm after each vaccine) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 36 days between doses of Moderna Covid-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. No treatment medication reported.   This case was linked to MOD-2021-402774 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Diarrhoea, Dizziness, Myalgia
Clinical narrative: stomach pain; Diarrhea; she became very Dizzy; Muscle aches; Nausea; Fever 104 F; This spontaneous case was reported by a nurse and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (Diarrhea), DIZZINESS (she became very Dizzy), MYALGIA (Muscle aches) and NAUSEA (Nausea) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939903 and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Nov-2021 at 4:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Nov-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (Diarrhea), DIZZINESS (she became very Dizzy), MYALGIA (Muscle aches), NAUSEA (Nausea) and PYREXIA (Fever 104 F). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (Diarrhea), DIZZINESS (she became very Dizzy), MYALGIA (Muscle aches), NAUSEA (Nausea) and PYREXIA (Fever 104 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Nov-2021, Body temperature: 104 (High) Fever 104 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.   This case was linked to MOD-2021-052696 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: stomach pain; Diarrhea; she became very Dizzy; Muscle aches; Nausea; Fever 104 F; This spontaneous case was reported by a nurse and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (Diarrhea), DIZZINESS (she became very Dizzy), MYALGIA (Muscle aches) and NAUSEA (Nausea) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939903 and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Nov-2021 at 4:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Nov-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (Diarrhea), DIZZINESS (she became very Dizzy), MYALGIA (Muscle aches), NAUSEA (Nausea) and PYREXIA (Fever 104 F). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (Diarrhea), DIZZINESS (she became very Dizzy), MYALGIA (Muscle aches), NAUSEA (Nausea) and PYREXIA (Fever 104 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Nov-2021, Body temperature: 104 (High) Fever 104 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.   This case was linked to MOD-2021-052696 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Extended interval between dose 1 & 2; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Extended interval between dose 1 & 2) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Extended interval between dose 1 & 2). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Extended interval between dose 1 & 2) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired Vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. DA2L2OA, 022M20A and 038B321A) for COVID-19 vaccination.     The patient's past medical history included Osteopenia, Chronic renal insufficiency, Thrombocytosis, Weight loss, Wrist pain (Wrist pain, right), Hypothyroidism, GERD, Edema (Edema, ankle left), Loss of taste, Anosmia, Polymyalgia rheumatica, Leukocytosis, Anemia, Wrist pain, Skin cancer, Cardiomyopathy, Cough, Cellulitis, Cholecystitis, Pancreatitis, Congestive heart failure, Arthralgia, Lung cancer, Lumbar radiculopathy (Lumbar radiculopathy, RIGHT), Sciatica (Sciatica, RIGHT), Skin cancer, Rotator cuff syndrome (Rotator cuff syndrome, left), Claudication, Knee pain, Sick sinus syndrome, Sinus bradycardia, Aortic stenosis, Prostate cancer (SCREENING FOR PROSTATE CANCER), Vitamin D (VITAMIN D, DEFICINECY), Tongue disorder, Dyspnea, Lumbar sprain, Atrial flutter, BPH, Coronary artery disease, Melanoma, High cholesterol and Cholecystectomy. Previously administered products included for Product used for unknown indication: INFLUENZA VACCINE on 10-Feb-2018, INFLUENZA VACCINE on 21-Oct-2019, INFLUENZA VACCINE on 18-Sep-2020, INFLUENZA VACCINE on 14-Sep-2021 and INFLUENZA VACCINE on 14-Sep-2021. Past adverse reactions to the above products included No adverse event with INFLUENZA VACCINE, INFLUENZA VACCINE, INFLUENZA VACCINE, INFLUENZA VACCINE and INFLUENZA VACCINE. Concomitant products included VITAMIN D3, CYANOCOBALAMIN (VITAMIN B-12), CARVEDILOL, SPIRONOLACTONE, APIXABAN (ELIQUIS), SACUBITRIL, VALSARTAN (ENTRESTO), FUROSEMIDE, TAMSULOSIN HCL, ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM GENERIC), PANTOPRAZOLE, IPRATROPIUM BROMIDE, LEVOTHYROXINE SODIUM and PREDNISONE for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used). On 28-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information not provided.  Treatment information not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 1st dose 02Mar2021; 2nd dose 14Apr2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 02Mar2021; 2nd dose 14Apr2021) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 02Mar2021; 2nd dose 14Apr2021). On 14-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 02Mar2021; 2nd dose 14Apr2021) had resolved.            No concomitant medication were reported. No treatment medication were reported.  Did not have the reactions after she got the 1st 2 doses, were reported.   This case was linked to MOD-2021-403149 (Patient Link).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Hyperhidrosis
Clinical narrative: Fell while coming back from the rest room to bed/Crawl back to bed/Don't know what happened after he got back to bed; Broke out in sweat; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell while coming back from the rest room to bed/Crawl back to bed/Don't know what happened after he got back to bed) and HYPERHIDROSIS (Broke out in sweat) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced FALL (Fell while coming back from the rest room to bed/Crawl back to bed/Don't know what happened after he got back to bed) and HYPERHIDROSIS (Broke out in sweat). At the time of the report, FALL (Fell while coming back from the rest room to bed/Crawl back to bed/Don't know what happened after he got back to bed) and HYPERHIDROSIS (Broke out in sweat) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drug details were reported. No treatment details were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: a bad night after dose 2; chills after dose 2; fatigue after dose 2; headache after dose 2; muscle pain after dose 2; joint pain after dose 2; fever after dose 2; nausea after dose 2; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (a bad night after dose 2), CHILLS (chills after dose 2), FATIGUE (fatigue after dose 2), HEADACHE (headache after dose 2) and MYALGIA (muscle pain after dose 2) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Pain. Concomitant products included MELOXICAM for Pain.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced VACCINATION COMPLICATION (a bad night after dose 2), CHILLS (chills after dose 2), FATIGUE (fatigue after dose 2), HEADACHE (headache after dose 2), MYALGIA (muscle pain after dose 2), ARTHRALGIA (joint pain after dose 2), PYREXIA (fever after dose 2) and NAUSEA (nausea after dose 2). At the time of the report, VACCINATION COMPLICATION (a bad night after dose 2), CHILLS (chills after dose 2), FATIGUE (fatigue after dose 2), HEADACHE (headache after dose 2), MYALGIA (muscle pain after dose 2), ARTHRALGIA (joint pain after dose 2), PYREXIA (fever after dose 2) and NAUSEA (nausea after dose 2) outcome was unknown.            The patient's conmeds included  blood pressure medication and cholesterol medication. No treatment was reported.  The reporter did not consent for follow up and remains anonymous on the report.   This case was linked to MOD-2021-402860, MOD-2021-402843 (Patient Link).   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination complication
Clinical narrative: a bad night after dose 2; chills after dose 2; fatigue after dose 2; headache after dose 2; muscle pain after dose 2; joint pain after dose 2; fever after dose 2; nausea after dose 2; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (a bad night after dose 2), CHILLS (chills after dose 2), FATIGUE (fatigue after dose 2), HEADACHE (headache after dose 2) and MYALGIA (muscle pain after dose 2) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Pain. Concomitant products included MELOXICAM for Pain.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced VACCINATION COMPLICATION (a bad night after dose 2), CHILLS (chills after dose 2), FATIGUE (fatigue after dose 2), HEADACHE (headache after dose 2), MYALGIA (muscle pain after dose 2), ARTHRALGIA (joint pain after dose 2), PYREXIA (fever after dose 2) and NAUSEA (nausea after dose 2). At the time of the report, VACCINATION COMPLICATION (a bad night after dose 2), CHILLS (chills after dose 2), FATIGUE (fatigue after dose 2), HEADACHE (headache after dose 2), MYALGIA (muscle pain after dose 2), ARTHRALGIA (joint pain after dose 2), PYREXIA (fever after dose 2) and NAUSEA (nausea after dose 2) outcome was unknown.            The patient's conmeds included  blood pressure medication and cholesterol medication. No treatment was reported.  The reporter did not consent for follow up and remains anonymous on the report.   This case was linked to MOD-2021-402860, MOD-2021-402843 (Patient Link).   Reporter did not allow further contact
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Illness, Myalgia, Pyrexia
Clinical narrative: chills After the first and second doses; feverish After the first and second doses; body ache After the first and second doses/muscle ache/pain for 2 days; sick for 2 days After the first and second doses; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick for 2 days After the first and second doses), CHILLS (chills After the first and second doses), PYREXIA (feverish After the first and second doses) and MYALGIA (body ache After the first and second doses/muscle ache/pain for 2 days) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick for 2 days After the first and second doses), CHILLS (chills After the first and second doses), PYREXIA (feverish After the first and second doses) and MYALGIA (body ache After the first and second doses/muscle ache/pain for 2 days). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, ILLNESS (sick for 2 days After the first and second doses), CHILLS (chills After the first and second doses), PYREXIA (feverish After the first and second doses) and MYALGIA (body ache After the first and second doses/muscle ache/pain for 2 days) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications were not reported.   This case was linked to MOD-2021-402913, MOD-2021-402894 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: fatigue; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), CHILLS (chills) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue), CHILLS (chills) and HEADACHE (headache). At the time of the report, FATIGUE (fatigue), CHILLS (chills) and HEADACHE (headache) had not resolved.            Treatment medication was not provided.  Concomitant medication was not provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Moderna vaccine administered to a patient on the 21st puncture of the vial; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine administered to a patient on the 21st puncture of the vial) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine administered to a patient on the 21st puncture of the vial). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine administered to a patient on the 21st puncture of the vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received a booster dose prior to 6 months of second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received a booster dose prior to 6 months of second dose) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer COVID-19 vaccine (Lot number :EW0217) on 14-Jun-2021 and Pfizer COVID-19 vaccine (Lot number :EW0181) on 07-Jul-2021. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccine and Pfizer COVID-19 vaccine.    On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Dec-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received a booster dose prior to 6 months of second dose). On 01-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received a booster dose prior to 6 months of second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication use was unknown Treatment information was unknown
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Malaise, Vaccination site pain
Clinical narrative: did not feel great the next day; malaise/felt blah; sore right arm after second shot; This spontaneous case was reported by a non-health professional and describes the occurrence of FEELING ABNORMAL (did not feel great the next day), MALAISE (malaise/felt blah) and VACCINATION SITE PAIN (sore right arm after second shot) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced MALAISE (malaise/felt blah). 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore right arm after second shot). On 10-Feb-2021, the patient experienced FEELING ABNORMAL (did not feel great the next day). At the time of the report, FEELING ABNORMAL (did not feel great the next day), MALAISE (malaise/felt blah) and VACCINATION SITE PAIN (sore right arm after second shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details were provided. No treatment medication details were reported.   This case was linked to MOD-2021-403976, MOD-2021-404031 (Patient Link).
Age: 19.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: patients received a dose of a vial after 12 hours of initial puncture; Vial stored in refrigerator once punctured, in freezer prior to puncture; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients received a dose of a vial after 12 hours of initial puncture) and PRODUCT STORAGE ERROR (Vial stored in refrigerator once punctured, in freezer prior to puncture) in an 18-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced PRODUCT STORAGE ERROR (Vial stored in refrigerator once punctured, in freezer prior to puncture). On 07-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients received a dose of a vial after 12 hours of initial puncture). On 07-Jun-2021, EXPIRED PRODUCT ADMINISTERED (patients received a dose of a vial after 12 hours of initial puncture) had resolved. At the time of the report, PRODUCT STORAGE ERROR (Vial stored in refrigerator once punctured, in freezer prior to puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications provided. There are two different lot numbers involved in this event. Lot numbers involved: lot 939902 with expiry (manufacturer) 17-Jan-2022,lot 047C21A with expiry (manufacturer) 07 Nov 2021. No adverse events reported after the vaccine.   This case was linked to MOD-2021-423398, MOD-2021-423397, MOD-2021-423357, MOD-2021-423048, MOD-2021-423373, MOD-2021-423320, MOD-2021-423437 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Dec-2021: Patient demographics, Dose information, Event information was updated. On 21-Dec-2021: Follow up received on 21-Dec-2021 contains Non significant information.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: A little bit of a cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (A little bit of a cold) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu shot (Flu shot). Past adverse reactions to the above products included No adverse event with Flu shot.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (A little bit of a cold). At the time of the report, NASOPHARYNGITIS (A little bit of a cold) outcome was unknown.            No concomitant medications were reported.  Treatment information was not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: now experiencing hair loss even more this morning, whole braid came out; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (now experiencing hair loss even more this morning, whole braid came out) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis and Pre-diabetic. Concomitant products included METFORMIN for Diabetic, PARACETAMOL (TYLENOL [PARACETAMOL]) for Pain, LEFLUNOMIDE for Rheumatoid arthritis, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HCTZ), AMITRIPTYLINE, COLECALCIFEROL (VITAMIN D3), CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), BIOTIN and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 13-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In December 2021, the patient experienced ALOPECIA (now experiencing hair loss even more this morning, whole braid came out). At the time of the report, ALOPECIA (now experiencing hair loss even more this morning, whole braid came out) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient experiencing hair loss. she started noticing it a couple of days ago and even more this morning. Her natural hair is braided. Her whole braid came out.  No treatment information details were reported.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: past the expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (past the expiration date) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (past the expiration date). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (past the expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort
Clinical narrative: rush in the brain after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (rush in the brain after the first dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (rush in the brain after the first dose). At the time of the report, HEAD DISCOMFORT (rush in the brain after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient has heart issues. No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-403018 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Groin pain, Toothache
Clinical narrative: Tooth ache; sore groin; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (Tooth ache) and GROIN PAIN (sore groin) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 04-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced TOOTHACHE (Tooth ache) and GROIN PAIN (sore groin). At the time of the report, TOOTHACHE (Tooth ache) and GROIN PAIN (sore groin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: booster doses administered after expiration date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date). On 09-Nov-2021, EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided. HCP called to ask about stability of expired vaccine given to patients. HCP said that 80 patients (may be less) received an expired booster dose. Vaccines were given on 8, 9, 10, 11, 12, 15, 16, 17, 18, 19 and 22 of November. HCP did not have # of doses given each day but said that on average, 6-7 doses were given per day. HCP also stated that it is possible he had used 2 vials in the same day. All booster doses were injected intramuscularly in deltoid muscle.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: booster doses administered after expiration date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date). On 17-Nov-2021, EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.            No treatment information was provided.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication were reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: arm is quite sore and red and hot; arm is quite sore and red and hot; arm is quite sore and red and hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm is quite sore and red and hot), VACCINATION SITE PAIN (arm is quite sore and red and hot) and VACCINATION SITE ERYTHEMA (arm is quite sore and red and hot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Dec-2021, the patient experienced VACCINATION SITE WARMTH (arm is quite sore and red and hot), VACCINATION SITE PAIN (arm is quite sore and red and hot) and VACCINATION SITE ERYTHEMA (arm is quite sore and red and hot). The patient was treated with IBUPROFEN in December 2021 at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (arm is quite sore and red and hot), VACCINATION SITE PAIN (arm is quite sore and red and hot) and VACCINATION SITE ERYTHEMA (arm is quite sore and red and hot) had not resolved.            No concomitant medications were reported  Non drug treatment include icepack
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash pruritic, Vaccination site rash
Clinical narrative: rash is sore; rash itches; developed a rash on her right arm/Feels like a Mosquito bite/The rash is in the one spot  on my right arm. next to where I got the Moderna shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (rash is sore), RASH PRURITIC (rash itches) and VACCINATION SITE RASH (developed a rash on her right arm/Feels like a Mosquito bite/The rash is in the one spot  on my right arm. next to where I got the Moderna shot) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H2A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Dec-2021, the patient experienced VACCINATION SITE RASH (developed a rash on her right arm/Feels like a Mosquito bite/The rash is in the one spot  on my right arm. next to where I got the Moderna shot). On an unknown date, the patient experienced PAIN (rash is sore) and RASH PRURITIC (rash itches). At the time of the report, PAIN (rash is sore), RASH PRURITIC (rash itches) and VACCINATION SITE RASH (developed a rash on her right arm/Feels like a Mosquito bite/The rash is in the one spot  on my right arm. next to where I got the Moderna shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by reporter. No treatment information was provided by reporter.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: I received my booster too soon/ I got my booster 4 months after 2 vaccine / booster given too early; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I received my booster too soon/ I got my booster 4 months after 2 vaccine / booster given too early) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I received my booster too soon/ I got my booster 4 months after 2 vaccine / booster given too early). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I received my booster too soon/ I got my booster 4 months after 2 vaccine / booster given too early) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported No treatment medication reported
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: After my second vaccine I had a headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (After my second vaccine I had a headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced HEADACHE (After my second vaccine I had a headache). At the time of the report, HEADACHE (After my second vaccine I had a headache) outcome was unknown.            No Treatment medications were provided No  Concomitant medications were provided patient would like to know where to go to receive her booster dose   This case was linked to MOD-2021-404082 (Patient Link).
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Injection site pain, Pain, Pyrexia
Clinical narrative: Sore arm at injection site.  Fever, chills, aching
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, C-reactive protein increased, Chest pain, Dyspnoea, Echocardiogram abnormal
Clinical narrative: Pericarditis. Awful. Started feeling some slight chest pain on 12/22. Felt it more or less continuously for a few days, but nothing severe, until the evening of 12/24. I woke up at 11 pm with severe pain and difficulty lying down and taking a deep breath. Severe chest pains and pain throughout my neck and throat. Went to the ER. They did an EKG and ran some blood tests. My CRP was at a 5, leading them to think I had some sort of infection. EKG was normal, didn't show that I had or was having a heart attack or anything, thank God. They sent me home.  Next day, I saw a cardiologist who performed an ultrasound and that showed pericardial effusion around the heart and some fluid buildup around the lungs. Diagnosed it as pericarditis. Prescribed ibuprofen -- 3 pills 3 x a day -- with food. Went back on 12/28 and the fluid around my heart was gone and the fluid around my lungs had diminished from 20 mm to 16 mm. On 12/28, Cardiologist, along with pulmonologist, reduced my ibuprofen to 2 (400 mg tablets) 2x a day. Feeling much better than on 12/24, when I thought I might be having a heart attack despite no history of heart problems in my family at such a young age.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Feeling abnormal, Infection, Mobility decreased, Neck pain
Clinical narrative: Pericarditis. Awful. Started feeling some slight chest pain on 12/22. Felt it more or less continuously for a few days, but nothing severe, until the evening of 12/24. I woke up at 11 pm with severe pain and difficulty lying down and taking a deep breath. Severe chest pains and pain throughout my neck and throat. Went to the ER. They did an EKG and ran some blood tests. My CRP was at a 5, leading them to think I had some sort of infection. EKG was normal, didn't show that I had or was having a heart attack or anything, thank God. They sent me home.  Next day, I saw a cardiologist who performed an ultrasound and that showed pericardial effusion around the heart and some fluid buildup around the lungs. Diagnosed it as pericarditis. Prescribed ibuprofen -- 3 pills 3 x a day -- with food. Went back on 12/28 and the fluid around my heart was gone and the fluid around my lungs had diminished from 20 mm to 16 mm. On 12/28, Cardiologist, along with pulmonologist, reduced my ibuprofen to 2 (400 mg tablets) 2x a day. Feeling much better than on 12/24, when I thought I might be having a heart attack despite no history of heart problems in my family at such a young age.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pericardial effusion, Pericarditis, Pulmonary oedema
Clinical narrative: Pericarditis. Awful. Started feeling some slight chest pain on 12/22. Felt it more or less continuously for a few days, but nothing severe, until the evening of 12/24. I woke up at 11 pm with severe pain and difficulty lying down and taking a deep breath. Severe chest pains and pain throughout my neck and throat. Went to the ER. They did an EKG and ran some blood tests. My CRP was at a 5, leading them to think I had some sort of infection. EKG was normal, didn't show that I had or was having a heart attack or anything, thank God. They sent me home.  Next day, I saw a cardiologist who performed an ultrasound and that showed pericardial effusion around the heart and some fluid buildup around the lungs. Diagnosed it as pericarditis. Prescribed ibuprofen -- 3 pills 3 x a day -- with food. Went back on 12/28 and the fluid around my heart was gone and the fluid around my lungs had diminished from 20 mm to 16 mm. On 12/28, Cardiologist, along with pulmonologist, reduced my ibuprofen to 2 (400 mg tablets) 2x a day. Feeling much better than on 12/24, when I thought I might be having a heart attack despite no history of heart problems in my family at such a young age.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound chest
Clinical narrative: Pericarditis. Awful. Started feeling some slight chest pain on 12/22. Felt it more or less continuously for a few days, but nothing severe, until the evening of 12/24. I woke up at 11 pm with severe pain and difficulty lying down and taking a deep breath. Severe chest pains and pain throughout my neck and throat. Went to the ER. They did an EKG and ran some blood tests. My CRP was at a 5, leading them to think I had some sort of infection. EKG was normal, didn't show that I had or was having a heart attack or anything, thank God. They sent me home.  Next day, I saw a cardiologist who performed an ultrasound and that showed pericardial effusion around the heart and some fluid buildup around the lungs. Diagnosed it as pericarditis. Prescribed ibuprofen -- 3 pills 3 x a day -- with food. Went back on 12/28 and the fluid around my heart was gone and the fluid around my lungs had diminished from 20 mm to 16 mm. On 12/28, Cardiologist, along with pulmonologist, reduced my ibuprofen to 2 (400 mg tablets) 2x a day. Feeling much better than on 12/24, when I thought I might be having a heart attack despite no history of heart problems in my family at such a young age.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Malaise, Musculoskeletal stiffness
Clinical narrative: headache, muscle ache, sore and stiff arm at injection site, fatigue, feeling unwell - starting about 90min after injection and subsiding after about 2 days
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: headache, muscle ache, sore and stiff arm at injection site, fatigue, feeling unwell - starting about 90min after injection and subsiding after about 2 days